000			02005 a2200529 4500
005			20250514050302.0
264		0	_c20021113
008			200211s 0 0 eng d
022			_a0022-4804
024	7		_a10.1006/jsre.2002.6500 _2doi
040			_aNLM _beng _cNLM
100	1		_aKuo, Yur-Ren
245	0	0	_aPlatelet glycoprotein IIb/IIIa receptor antagonist (abciximab) inhibited platelet activation and promoted skin flap survival after ischemia/reperfusion injury. _h[electronic resource]
260			_bThe Journal of surgical research _cSep 2002
300			_a50-5 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAbciximab
650	0	4	_aAdenosine Diphosphate _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aBlood Platelets _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEndothelium, Vascular _xdrug effects
650	0	4	_aImmunoglobulin Fab Fragments _xadministration & dosage
650	0	4	_aIschemia _xphysiopathology
650	0	4	_aMale
650	0	4	_aP-Selectin _xmetabolism
650	0	4	_aPlatelet Activation _xdrug effects
650	0	4	_aPlatelet Aggregation _xdrug effects
650	0	4	_aPlatelet Count
650	0	4	_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors
650	0	4	_aRats
650	0	4	_aRats, Inbred Lew
650	0	4	_aRegional Blood Flow _xdrug effects
650	0	4	_aReperfusion Injury _xphysiopathology
650	0	4	_aSkin _xblood supply
650	0	4	_aSurgical Flaps _xphysiology
650	0	4	_aTime Factors
650	0	4	_aTissue Survival _xdrug effects
700	1		_aJeng, Seng-Feng
700	1		_aWang, Feng-Sheng
700	1		_aHuang, Hui-Chen
700	1		_aWei, Fu-Chan
700	1		_aYang, Kuender D
773	0		_tThe Journal of surgical research _gvol. 107 _gno. 1 _gp. 50-5
856	4	0	_uhttps://doi.org/10.1006/jsre.2002.6500 _zAvailable from publisher's website
999			_c12193329 _d12193329